×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)

NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)

货号:CL-0275

规格:1×10⁶cells/T25培养瓶

价格: ¥1400

生长培养基:RPMI-164010% FBS1% P/S

数量: - +

  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
  • NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

NCI-H1395 (人肺腺癌细胞) (STR鉴定正确) ¥1400
NCI-H1395细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1750¥1850

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 NCI-H1395 (人肺腺癌细胞) (STR鉴定正确)
别称 H1395; H-1395; NCIH1395
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:3-1:4
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 NCI-H1395细胞是于1986年4月建株的,组织提供者吸烟、每年15包;NCI-BL1395 [BL1395]细胞是一株来源于同一患者的类淋巴母细胞。
年龄(性别) 女性;55岁
组织来源
细胞类型 肿瘤细胞
肿瘤类型 肺癌细胞
生物安全等级 BSL-1
保藏机构 ATCC; CRL-5868
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 12
    D2S1338 17,24
    D3S1358 15
    D5S818 12
    D7S820 8
    D8S1179 12,14
    D13S317 10,14
    D16S539 11,13
    D18S51 12,14
    D19S433 13,16
    D21S11 29
    FGA 18,23
    PentaD 12
    PentaE 7
    TH01 6,9.3
    TPOX 8
    vWA 14,17
    D6S1043 18,19
    D12S391 20,22
    D2S441 10,11
  • STR鉴定图
参考文献
文献列表
  • Activation of Hypoxia Inducible Factor-1 Alpha-Mediated DNA Methylation Enzymes (DNMT3a and TET2) Under Hypoxic Conditions Regulates S100A6 Transcription to Promote Lung Cancer Cell Growth and Metastasis (2024-03-18)

    作者:Tengfei Wang:1.The Department of Thoracic Surgery; Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China. ; Genbao Zhu:1.General Clinical Research Center; Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China. ; Bo Wang:1.The Department of Thoracic Surgery; Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China. ; Mengxue Hu:1.General Clinical Research Center; Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China. ; Chen Gong:1.General Clinical Research Center; Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China. ; Kemeng Tan:1.General Clinical Research Center; Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China. ; La Jiang:1.General Clinical Research Center; Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China. ; Xiaohong Zhu:1.General Clinical Research Center; Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, China. ; Yuliu Geng:1.The Department of Thoracic Surger

    期刊:Activation of Hypoxia Inducible Factor-1 Alpha-Mediated DNA Methylation Enzymes (DNMT3a and TET2) Under Hypoxic Conditions Regulates S100A6 Transcription to Promote Lung Cancer Cell Growth and Metastasis

    DOI:10.1089/ars.2023.0397

    影响因子 :6.6

    引用产品: BEAS-2B 细胞 ,  Calu-3 细胞 ,  NCI-H1395 细胞 ,  NCI-H1975 细胞 ,  A549 [A-549] 细胞

  • Diterpenoid honatisine overcomes temozolomide resistance in glioblastoma by inducing mitonuclear protein imbalance through disruption of TFAM-mediated mtDNA transcription (2023-12-29)

    作者:Zongyang Li:1.Department of Neurosurgery, Shenzhen Key Laboratory of Neurosurgery, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, 3002# Sungang Road, Futian District, Shenzhen 518035, China. ; Ke Sai:1.Department of Neurosurgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China. ; Guoxu Ma:1.Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China. ; Fanfan Chen:1.Department of Neurosurgery, Shenzhen Key Laboratory of Neurosurgery, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, 3002# Sungang Road, Futian District, Shenzhen 518035, China. ; Xudong Xu:1.Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China. ; Lei Chen:1.Department of

    期刊:Diterpenoid honatisine overcomes temozolomide resistance in glioblastoma by inducing mitonuclear protein imbalance through disruption of TFAM-mediated mtDNA transcription

    DOI:10.1016/j.phymed.2023.155328

    影响因子 :7.9

    引用产品: SK-OV-3 细胞 ,  Caco-2 细胞 ,  PANC-1 细胞 ,  PC-3 细胞 ,  NCI-H1395 细胞 ,  MCF7 [MCF-7] 细胞

  • Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling (2005-01-20)

    作者:Aibin Liu:1.Department of Geriatrics, Xiangya Hospital, Central South University, Changsha 410008, China. ; 2.National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China. ; Huayan Xie:1.Department of Geriatrics, Xiangya Hospital, Central South University, Changsha 410008, China. ; Ronggang Li:1.Department of Pathology, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen 529030, China. ; Liangliang Ren:1.Clinical Experimental Center, Jiangmen Key Laboratory of Clinical Biobanks and Translational Research, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen 529030, China. ; Baishuang Yang:1.Department of Geriatrics, Xiangya Hospital, Central South University, Changsha 410008, China. ; Longxia Dai:1.Department of Geriatrics, Xiangya Hospital, Central South University, Changsha 410008, China. ; Wenjie Lu:1.Clinical Experimental Center, Jian

    期刊:Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling

    DOI:10.1016/j.omto.2021.05.008

    影响因子 :5.7

    引用产品: NCI-H1975 细胞 ,  NCI-H1395 细胞 ,  NCI-H520 细胞 ,  A549/DDP 细胞 ,  NCI-H1299 细胞

  • Identification of differentially expressed genes using microarray analysis and COL6A1 induction of bone metastasis in non‑small cell lung cancer (2008-01-20)

    作者:Nan Li:1.Department of Radiotherapy and Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China. ; Ming Liu:1.Department of Radiotherapy and Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China. ; Xiaohui Cao:1.Department of Radiotherapy and Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China. ; Wei Li:1.Department of Radiotherapy and Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China. ; Yunfang Li:1.Department of Radiotherapy and Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China. ; Zongmao Zhao:1.Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China. ;

    期刊:Identification of differentially expressed genes using microarray analysis and COL6A1 induction of bone metastasis in non‑small cell lung cancer

    DOI:10.3892/ol.2021.12954

    影响因子 :2.9

    引用产品: NCI-H1395 细胞 ,  M-7 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号